Products
Fosaprepitant is commercially available as an infusion preparation (Ivemend). It has been approved in many countries since 2008.
Structure and properties
Fosaprepitant (C23H22F7N4O6P, Mr = 614.4 g/mol) is the prodrug of aprepitant (Emend). Unlike aprepitant, which is administered orally, fosaprepitant is administered parenterally and is more water soluble.
Detailed information
See under aprepitant